Summary: Dr. John Talley is Co-Founder and CSO of Euclises Pharmaceuticals. He is also Co-Founder, Partner, and VP of Chemistry at Emmyon. John is developing non-opioid treatments for acute and chronic pain and developing a new medicine to be used with immune checkpoint inhibitors to slow or reverse tumor growth in cancer. In his free time, John enjoys cultivating vegetables and flowers in his garden, as well as growing indoor plants. He also likes to travel, go camping with his family, and play with his three cats
